PTC Therapeutics Inc (PTCT)
43.23
+0.34
(+0.79%)
USD |
NASDAQ |
Nov 22, 16:00
43.23
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Cash from Financing (Quarterly): -17.63M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -17.63M |
| June 30, 2024 | 246.48M |
| March 31, 2024 | 0.54M |
| December 31, 2023 | 620.48M |
| September 30, 2023 | 3.361M |
| June 30, 2023 | 18.46M |
| March 31, 2023 | 4.094M |
| December 31, 2022 | 302.92M |
| September 30, 2022 | -140.00M |
| June 30, 2022 | 3.861M |
| March 31, 2022 | 1.168M |
| December 31, 2021 | 4.354M |
| September 30, 2021 | 2.976M |
| June 30, 2021 | 4.016M |
| March 31, 2021 | 9.531M |
| December 31, 2020 | 40.09M |
| September 30, 2020 | 643.05M |
| June 30, 2020 | -32.92M |
| March 31, 2020 | 18.49M |
| December 31, 2019 | 2.284M |
| September 30, 2019 | 382.35M |
| June 30, 2019 | 2.849M |
| March 31, 2019 | 225.72M |
| December 31, 2018 | 3.726M |
| September 30, 2018 | 5.08M |
| Date | Value |
|---|---|
| June 30, 2018 | 121.63M |
| March 31, 2018 | 1.136M |
| December 31, 2017 | 1.851M |
| September 30, 2017 | 1.707M |
| June 30, 2017 | 40.00M |
| March 31, 2017 | 0.663M |
| December 31, 2016 | 0.042M |
| September 30, 2016 | 0.892M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.034M |
| December 31, 2015 | 0.022M |
| September 30, 2015 | 145.97M |
| June 30, 2015 | 5.053M |
| March 31, 2015 | 3.019M |
| December 31, 2014 | 118.40M |
| September 30, 2014 | 0.359M |
| June 30, 2014 | 0.218M |
| March 31, 2014 | 118.15M |
| December 31, 2013 | -0.036M |
| September 30, 2013 | -2.856M |
| June 30, 2013 | 134.94M |
| March 31, 2013 | 55.39M |
| December 31, 2012 | -0.7036M |
| September 30, 2012 | -1.577M |
| June 30, 2012 | 27.02M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-140.00M
Minimum
Sep 2022
643.05M
Maximum
Sep 2020
86.78M
Average
4.055M
Median
Cash from Financing (Quarterly) Benchmarks
| ClearPoint Neuro Inc | -10.06M |
| Pfizer Inc | -4.636B |
| Vertex Pharmaceuticals Inc | -387.50M |
| BridgeBio Pharma Inc | 0.707M |
| Cassava Sciences Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -76.99M |
| Cash from Investing (Quarterly) | -42.68M |
| Free Cash Flow | -274.19M |
| Free Cash Flow Per Share (Quarterly) | -1.141 |
| Free Cash Flow to Equity (Quarterly) | -88.07M |
| Free Cash Flow to Firm (Quarterly) | -42.48M |
| Free Cash Flow Yield | -8.30% |